Understanding the companion-diagnostics environment

The first companion diagnostics were launched in the 1980s in the face of significant skepticism from drug developers as to whether segmenting a drug’s market through a diagnostic was advisable. The commercial success of Herceptin (trastuzumab) and Gleevec (imatinib), which […]

Read More

HPCLC Spring Meeting recap

On March 24-26, more than 100 supply chain and logistics professionals convened in Philadelphia for the semiannual Health and Personal Care Logistic Conference (HPCLC). Since the 1920s, HPCLC has been addressing relevant and current topics facing logistics professionals in the […]

Read More

Pharmaceutical Commerce at 10

I get impatient with my writers who sometimes start articles with events that occurred in 1995 or 1985 or even 1875—I love histories, but Pharmaceutical Commerce is not a place to go to for the history of most anything. Nevertheless, […]

Read More

A Conversation with Shabbir Dahod, TraceLink

The Drug Supply Chain Security Act (DSCSA) was passed in 2013 with a complex schedule of deadlines starting this year and continuing into the early 2020s. That mandate is generating a dramatic upswing in pharma industry capital investment and operational […]

Read More

A Big Data approach to patient engagement and adherence

Telerx’s Adaptive Command Center centralizes the services that can be offered to patients. Credit: Telerx Health data from digital channels is exploding. Whether companies gain insights through analytics from pharmaceutical research, social media, wearable technologies, health records or other sources, […]

Read More

2015 Product Security Report

Fig. 1. Even with a global push for unit serialization via barcodes, there are national variations. The land rush is on. After years of wrangling over compliance requirements for serialization and traceability in the US pharma supply chain, manufacturers and […]

Read More

Compliance packaging vendors keep innovating

Fig. 1 AstraZeneca’s Seroquel (top), the 2014 HCPC winner; Lilly’s Strattera (middle); Novartis’ Exforge (bottom) Pharma manufacturers (and their contract packaging providers) who are considering compliance (unit-dose) packaging have three trends to take advantage of: More of the overall healthcare […]

Read More